Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ironwood Pharmaceuticals Long Term Debt 2010-2024 | IRWD

Ironwood Pharmaceuticals long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  
Ironwood Pharmaceuticals Annual Long Term Debt
(Millions of US $)
2023 $498
2022 $396
2021 $
2020 $430
2019 $408
2018 $366
2017 $396
2016 $367
2015 $354
2014 $161
2013 $178
2012 $0
2011 $0
2010 $0
2009 $1
Ironwood Pharmaceuticals Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $599
2024-06-30 $624
2024-03-31 $473
2023-12-31 $498
2023-09-30 $523
2023-06-30 $598
2023-03-31
2022-12-31 $396
2022-09-30 $396
2022-06-30 $395
2022-03-31 $395
2021-12-31
2021-09-30 $333
2021-06-30 $329
2021-03-31 $436
2020-12-31 $430
2020-09-30 $425
2020-06-30 $419
2020-03-31 $426
2019-12-31 $408
2019-09-30 $403
2019-06-30 $353
2019-03-31 $360
2018-12-31 $366
2018-09-30 $370
2018-06-30 $380
2018-03-31 $388
2017-12-31 $396
2017-09-30 $392
2017-06-30 $388
2017-03-31 $384
2016-12-31 $367
2016-09-30 $363
2016-06-30 $339
2016-03-31 $349
2015-12-31 $354
2015-09-30 $360
2015-06-30 $364
2015-03-31 $160
2014-12-31 $161
2014-09-30 $168
2014-06-30 $171
2014-03-31 $173
2013-12-31 $178
2013-09-30 $178
2013-06-30 $175
2013-03-31 $175
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $1
2011-03-31 $1
2010-12-31 $0
2010-09-30 $0
2010-06-30 $2
2010-03-31 $2
2009-12-31 $1
2009-09-30 $2
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.595B $0.443B
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic constipation. Ironwood and AbbVie co-develop & co-commercialize Linzess in all other territories world wide. Linzess is marketed by Allergan for IBS-C in Europe and Canada under the brand name Constella. The company receives royalties on sales of Constella in Europe and Canada from AbbVie. In Japan, it has partnered with Astellas Pharma for the development and commercialization of Linzess and with AstraZeneca in China, Hong Kong & Macau. Linzess received approval for IBS-C indication in Japan for chronic constipation and in China for IBS-C. The company completed the spin-off of its soluble guanylate cyclase segment into a separate, publicly traded company, Cyclerion Therapeutics.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.797B 29.55
Chugai Pharmaceutical (CHGCY) Japan $66.907B 26.06
Takeda Pharmaceutical (TAK) Japan $42.351B 8.81
Sandoz Group AG (SDZNY) Switzerland $20.614B 0.00
Merck (MKKGY) Germany $20.007B 17.92
Astellas Pharma (ALPMY) Japan $17.699B 16.30
United Therapeutics (UTHR) United States $16.641B 16.37
Summit Therapeutics (SMMT) United States $15.958B 0.00
Neurocrine Biosciences (NBIX) United States $15.256B 40.40
Shionogi (SGIOY) Japan $12.454B 12.48
Orion OYJ (ORINY) Finland $7.529B 21.17
Madrigal Pharmaceuticals (MDGL) United States $7.117B 0.00
Stevanato Group S.p.A (STVN) Italy $6.493B 42.04
Corcept Therapeutics (CORT) United States $6.447B 48.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.192B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.937B 7.84
Grifols, S.A (GRFS) Spain $4.813B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.652B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.858B 12.95
Recursion Pharmaceuticals (RXRX) United States $2.798B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.705B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $2.236B 0.00
Soleno Therapeutics (SLNO) United States $2.128B 0.00
Hypermarcas (HYPMY) Brazil $1.926B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.920B 0.00
Indivior (INDV) United States $1.675B 6.83
BioCryst Pharmaceuticals (BCRX) United States $1.661B 0.00
Evotec AG (EVO) Germany $1.495B 0.00
Guardian Pharmacy Services (GRDN) United States $1.413B 0.00
ARS Pharmaceuticals (SPRY) United States $1.392B 0.00
Dyne Therapeutics (DYN) United States $1.378B 0.00
Xencor (XNCR) United States $1.318B 0.00
Ardelyx (ARDX) United States $1.298B 0.00
Ocular Therapeutix (OCUL) United States $1.233B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 0.00
Harrow (HROW) United States $1.152B 0.00
Collegium Pharmaceutical (COLL) United States $1.046B 5.71
Enliven Therapeutics (ELVN) United States $1.019B 0.00
Bioventus (BVS) United States $0.851B 26.90
Relay Therapeutics (RLAY) United States $0.750B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.738B 0.00
Cronos Group (CRON) Canada $0.719B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Verve Therapeutics (VERV) United States $0.652B 0.00
Xeris Biopharma Holdings (XERS) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
Elite Pharmaceuticals (ELTP) United States $0.500B 0.00
Altimmune (ALT) United States $0.494B 0.00
Organogenesis (ORGO) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.474B 0.00
ProKidney (PROK) United States $0.467B 0.00
Savara (SVRA) United States $0.458B 0.00
OmniAb (OABI) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.447B 5.22
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Oruka Therapeutics (ORKA) United States $0.422B 0.00
Zevra Therapeutics (ZVRA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 160.64
Esperion Therapeutics (ESPR) United States $0.372B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.308B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.277B 16.46
CytoDyn (CYDY) United States $0.255B 0.00
Heron Therapeutics (HRTX) United States $0.254B 0.00
Avita Medical (RCEL) United States $0.246B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.237B 0.00
Larimar Therapeutics (LRMR) United States $0.237B 0.00
4D Molecular Therapeutics (FDMT) United States $0.231B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Inhibikase Therapeutics (IKT) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Acrivon Therapeutics (ACRV) United States $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.172B 0.00
Lyell Immunopharma (LYEL) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Nanobiotix S.A (NBTX) France $0.163B 0.00
Silence Therapeutics (SLN) United Kingdom $0.157B 0.00
Nektar Therapeutics (NKTR) United States $0.154B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.117B 0.00
Inotiv (NOTV) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
Protara Therapeutics (TARA) United States $0.093B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Journey Medical (DERM) United States $0.082B 0.00
AleAnna (ANNA) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.75
Avalo Therapeutics (AVTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
AlloVir (ALVR) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
BioVie (BIVI) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mannatech (MTEX) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00